
Accuray (ARAY) Stock Forecast & Price Target
Accuray (ARAY) Analyst Ratings
Bulls say
Accuray is facing headwinds in terms of commercial execution, profitability metrics, and visibility. With longer-than-expected timelines for improvements and risks such as increased tariffs and geopolitical tensions, the company is facing challenges in converting orders to revenue and achieving profitability. However, the company's technology, the CyberKnife, has the potential to drive future growth and the stock currently trades at a discount compared to its peers.
Bears say
Accuray is facing multiple challenges with geopolitical uncertainty, macroeconomic headwinds, and difficulties in commercial execution and profitability metrics. Despite cost-cutting efforts, the company's transformation plan may not be enough to offset declining revenue and lack of visibility on a turnaround. Furthermore, with multiples contracting for the MedTech sector and little progress on profitability, investors may not have an appetite for this stock. The company's recent downgrade and removal of financial guidance for FY2026 also raises concerns about potential future challenges.
This aggregate rating is based on analysts' research of Accuray and is not a guaranteed prediction by Public.com or investment advice.
Accuray (ARAY) Analyst Forecast & Price Prediction
Start investing in Accuray (ARAY)
Order type
Buy in
Order amount
Est. shares
0 shares